{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:54Z","timestamp":1794047454058,"version":"4.8.0"},"reference-count":43,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"4","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Multiple myeloma (MM) is an incurable disease of the bone marrow (BM) characterized by the uncontrolled proliferation of neoplastic plasma cells. While CD8+ T cells have an established role in disease control, few studies have focused on these cells within the MM tumor microenvironment (TME). We analyzed CD8+ T cells in the BM and peripheral blood (PB) of untreated patients with MM and non-myeloma controls using flow cytometry, mass cytometry and single-cell RNA sequencing, using several novel bioinformatics workflows. Inter-tissue differences were most evident in the differential expression of Granzymes B and K, which were strongly associated with two distinct subsets of CD8+ T cells delineated by the expression of CD69, accounting for roughly 50% of BM-CD8+ T cells of all assessed cohorts. While few differences were observable between health and disease in the BM-restricted CD8CD69+ T-cell subset, the CD8+CD69- T-cell subset in the BM of untreated MM patients demonstrated increased representation of highly differentiated effector cells and evident compositional parallels between the PB, absent in age-matched controls, where a marked reduction of effector cells was observed. We demonstrate the transcriptional signature of BM-CD8+ T cells from patients with MM more closely resembles TCR-activated CD8+ T cells from age-matched controls than their resting counterparts.<\/jats:p>","DOI":"10.3324\/haematol.2023.283062","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T03:05:55Z","timestamp":1696475155000},"page":"1220-1232","source":"Crossref","is-referenced-by-count":4,"title":["Single-cell analysis of the CD8&lt;sup&gt;+&lt;\/sup&gt; T-cell compartment in multiple myeloma reveals disease specific changes are chiefly restricted to a CD69&lt;sup&gt;-&lt;\/sup&gt; subset suggesting potent cytotoxic effectors exist within the tumor bed"],"prefix":"10.3324","volume":"109","author":[{"given":"James","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian E.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Abadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najah","family":"Nassif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Sedger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas E.","family":"Joshua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Joy","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"59807","doi-asserted-by":"crossref","unstructured":"Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020; 95(5):548-567.","DOI":"10.1002\/ajh.25791"},{"key":"59808","doi-asserted-by":"crossref","unstructured":"Wang H, Leng Y, Gong Y. Bone marrow fat and hematopoiesis. Front Endocrinol (Lausanne). 2018; 9:694.","DOI":"10.3389\/fendo.2018.00694"},{"key":"59809","doi-asserted-by":"crossref","unstructured":"Di Rosa F, Gebhardt T. Bone marrow T cells and the integrated functions of recirculating and tissue-resident memory T cells. Front Immunol. 2016; 7:51.","DOI":"10.3389\/fimmu.2016.00051"},{"key":"59810","doi-asserted-by":"crossref","unstructured":"Lightman SM, Utley A, Lee KP. Survival of long-lived plasma cells (LLPC): piecing together the puzzle. Front Immunol. 2019; 10:965.","DOI":"10.3389\/fimmu.2019.00965"},{"key":"59811","doi-asserted-by":"crossref","unstructured":"Bruns I, Cadeddu RP, Brueckmann I. Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells. Blood. 2012; 120(13):2620-2630.","DOI":"10.1182\/blood-2011-04-347484"},{"key":"59812","doi-asserted-by":"crossref","unstructured":"Gooding S, Olechnowicz SWZ, Morris EV. Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signaling inhibition to improve bone disease. Nat Commun. 2019; 10(1):4533.","DOI":"10.1038\/s41467-019-12296-1"},{"key":"59813","doi-asserted-by":"crossref","unstructured":"Vuckovic S, Minnie SA, Smith D. Bone marrow transplantation generates T cell-dependent control of myeloma in mice. J Clin Invest. 2019; 129(1):106-121.","DOI":"10.1172\/JCI98888"},{"key":"59814","doi-asserted-by":"crossref","unstructured":"Bryant C, Suen H, Brown R. Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg\/Th17 balance. Blood Cancer J. 2013; 3(9):e148.","DOI":"10.1038\/bcj.2013.34"},{"key":"59815","doi-asserted-by":"crossref","unstructured":"Suen H, Brown R, Yang S. Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade. Leukemia. 2016; 30(8):1716-1724.","DOI":"10.1038\/leu.2016.84"},{"key":"59816","doi-asserted-by":"crossref","unstructured":"Suen H, Brown R, Yang S, Ho PJ, Gibson J, Joshua D. The failure of immune checkpoint blockade in multiple myeloma with PD-1 inhibitors in a phase 1 study. Leukemia. 2015; 29(7):1621-1622.","DOI":"10.1038\/leu.2015.104"},{"key":"59817","doi-asserted-by":"crossref","unstructured":"Shah N, Chari A, Scott E, Mezzi K, Usmani SZ. B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches. Leukemia. 2020; 34(4):985-1005.","DOI":"10.1038\/s41375-020-0734-z"},{"key":"59818","doi-asserted-by":"crossref","unstructured":"Vuckovic S, Bryant CE, Lau KHA. Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients. Blood Adv. 2020; 4(19):4593-4604.","DOI":"10.1182\/bloodadvances.2020002237"},{"key":"59819","doi-asserted-by":"crossref","unstructured":"Andreatta M, Corria-Osorio J, M\u00fcller S, Cubas R, Coukos G, Carmona SJ. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat Commun. 2021; 12(1):2965.","DOI":"10.1038\/s41467-021-23324-4"},{"key":"59820","doi-asserted-by":"crossref","unstructured":"Van Gassen S, Callebaut B, Van Helden MJ. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A. 2015; 87(7):636-645.","DOI":"10.1002\/cyto.a.22625"},{"key":"59821","doi-asserted-by":"crossref","unstructured":"Remmerswaal EBM, Hombrink P, Nota B. Expression of IL-7R\u03b1 and KLRG1 defines functionally distinct CD8(+) T-cell populations in humans. Eur J Immunol. 2019; 49(5):694-708.","DOI":"10.1002\/eji.201847897"},{"key":"59822","doi-asserted-by":"crossref","unstructured":"Wen S, Lu H, Wang D, Guo J, Dai W, Wang Z. TCF-1 maintains CD8(+) T cell stemness in tumor microenvironment. J Leukoc Biol. 2021; 110(3):585-590.","DOI":"10.1002\/JLB.5MR1120-778R"},{"key":"59823","doi-asserted-by":"crossref","unstructured":"Saraiva DP, Azeredo-Lopes S, Antunes A. Expression of HLA-DR in cytotoxic T lymphocytes: a validated predictive biomarker and a potential therapeutic strategy in breast cancer. Cancers. 2021; 13(15):3841.","DOI":"10.3390\/cancers13153841"},{"key":"59824","doi-asserted-by":"crossref","unstructured":"Szabo PA, Levitin HM, Miron M. Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease. Nat Commun. 2019; 10(1):4706.","DOI":"10.1038\/s41467-019-12464-3"},{"key":"59825","doi-asserted-by":"crossref","unstructured":"Goulart MR, Stasinos K, Fincham REA, Delvecchio FR, Kocher HM. T cells in pancreatic cancer stroma. World J Gastroenterol. 2021; 27(46):7956-7968.","DOI":"10.3748\/wjg.v27.i46.7956"},{"key":"59826","doi-asserted-by":"crossref","unstructured":"Abbas HA, Hao D, Tomczak K. Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy. Nat Commun. 2021; 12(1):6071.","DOI":"10.1038\/s41467-021-26282-z"},{"key":"59827","doi-asserted-by":"crossref","unstructured":"Nath K, Law SC, Sabdia MB. Intra-tumoral CD8+ T-cells in follicular lymphoma contain large clonal expansions that are amenable to dual-checkpoint blockade. Blood. 2019; 134:2793.","DOI":"10.1182\/blood-2019-130050"},{"key":"59828","doi-asserted-by":"crossref","unstructured":"Pilcher W, Thomas BE, Bhasin SS. Characterization of T-cell exhaustion in rapid progressing multiple myeloma using cross center Scrna-Seq study. Blood. 2021; 138:401.","DOI":"10.1182\/blood-2021-153863"},{"key":"59829","doi-asserted-by":"crossref","unstructured":"Zelle-Rieser C, Thangavadivel S, Biedermann R. T cells in multiple myeloma display features of exhaustion and senescence at the tumor site. J Hematol Oncol. 2016; 9(1):116.","DOI":"10.1186\/s13045-016-0345-3"},{"key":"59830","doi-asserted-by":"crossref","unstructured":"Kumar BV, Ma W, Miron M. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep. 2017; 20(12):2921-2934.","DOI":"10.1016\/j.celrep.2017.08.078"},{"key":"59831","doi-asserted-by":"crossref","unstructured":"Moreau P, Garfall AL, van de Donk N. Teclistamab in relapsed or refractory multiple myeloma. N Engl J Med. 2022; 387(6):495-505.","DOI":"10.1056\/NEJMoa2203478"},{"key":"59832","doi-asserted-by":"crossref","unstructured":"Chari A, Minnema MC, Berdeja JG. Talquetamab, a T-cell-redirecting GPRC5D bispecific antibody for multiple myeloma. N Engl J Med. 2022; 387(24):2232-2244.","DOI":"10.1056\/NEJMoa2204591"},{"key":"59833","doi-asserted-by":"crossref","unstructured":"Voskoboinik I, Whisstock JC, Trapani JA. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 2015; 15(6):388-400.","DOI":"10.1038\/nri3839"},{"key":"59834","doi-asserted-by":"crossref","unstructured":"Harari A, Bellutti Enders F, Cellerai C, Bart PA, Pantaleo G. Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure. J Virol. 2009; 83(7):2862-2871.","DOI":"10.1128\/JVI.02528-08"},{"key":"59835","doi-asserted-by":"crossref","unstructured":"Mogilenko DA, Shpynov O, Andhey PS. Comprehensive profiling of an aging immune system reveals clonal GZMK(+) CD8(+) T cells as conserved hallmark of inflammaging. Immunity. 2021; 54(1):99-115.","DOI":"10.1016\/j.immuni.2020.11.005"},{"key":"59836","doi-asserted-by":"crossref","unstructured":"Cooper DM, Pechkovsky DV, Hackett TL, Knight DA, Granville DJ. Granzyme K activates protease-activated receptor-1. PLoS One. 2011; 6(6):e21484.","DOI":"10.1371\/journal.pone.0021484"},{"key":"59837","doi-asserted-by":"crossref","unstructured":"Musolino C, Allegra A, Innao V, Allegra AG, Pioggia G, Gangemi S. Inflammatory and anti-inflammatory equilibrium, proliferative and antiproliferative balance: the role of cytokines in multiple myeloma. Mediators Inflamm. 2017; 2017:1852517.","DOI":"10.1155\/2017\/1852517"},{"key":"59838","doi-asserted-by":"crossref","unstructured":"de Jong MME, Kellermayer Z, Papazian N. The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape. Nat Immunol. 2021; 22(6):769-780.","DOI":"10.1038\/s41590-021-00931-3"},{"key":"59839","doi-asserted-by":"crossref","unstructured":"Zavidij O, Haradhvala NJ, Mouhieddine TH. Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nat Cancer. 2020; 1(5):493-506.","DOI":"10.1038\/s43018-020-0053-3"},{"key":"59840","doi-asserted-by":"crossref","unstructured":"Bailur JK, McCachren SS, Doxie DB. Early alterations in stemlike\/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy. JCI Insight. 2019; 5(11):e127807.","DOI":"10.1172\/jci.insight.127807"},{"key":"59841","doi-asserted-by":"crossref","unstructured":"Krejcik J, Casneuf T, Nijhof IS. Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma. Blood. 2016; 128(3):384-394.","DOI":"10.1182\/blood-2015-12-687749"},{"key":"59842","doi-asserted-by":"crossref","unstructured":"Cibri\u00e1n D, S\u00e1nchez-Madrid F. CD69: from activation marker to metabolic gatekeeper. Eur J Immunology. 2017; 47(6):946-953.","DOI":"10.1002\/eji.201646837"},{"key":"59843","doi-asserted-by":"crossref","unstructured":"Glavey SV, Naba A, Manier S. Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. Leukemia. 2017; 31(11):2426-2434.","DOI":"10.1038\/leu.2017.102"},{"key":"59844","doi-asserted-by":"crossref","unstructured":"Storti P, Marchica V, Airoldi I. Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo. Leukemia. 2016; 30(12):2351-2363.","DOI":"10.1038\/leu.2016.137"},{"key":"59845","doi-asserted-by":"crossref","unstructured":"Clemente T, Vieira NJ, Cerliani JP. Proteomic and functional analysis identifies galectin-1 as a novel regulatory component of the cytotoxic granule machinery. Cell Death Dis. 2017; 8(12):e3176.","DOI":"10.1038\/cddis.2017.506"},{"key":"59846","doi-asserted-by":"crossref","unstructured":"Dhodapkar KM, Cohen AD, Kaushal A. Changes in bone marrow tumor and immune cells correlate with durability of remissions following BCMA CAR T therapy in myeloma. Blood Cancer Discov. 2022; 3(6):490-501.","DOI":"10.1158\/2643-3230.BCD-22-0018"},{"key":"59847","doi-asserted-by":"crossref","unstructured":"Labiano S, Mel\u00e9ndez-Rodr\u00edguez F, Palaz\u00f3n A. CD69 is a direct HIF-1\u03b1 target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes. Oncoimmunology. 2017; 6(4):e1283468.","DOI":"10.1080\/2162402X.2017.1283468"},{"key":"59848","doi-asserted-by":"crossref","unstructured":"Doedens AL, Phan AT, Stradner MH. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol. 2013; 14(11):1173-1182.","DOI":"10.1038\/ni.2714"},{"key":"59849","doi-asserted-by":"crossref","unstructured":"Xu Y, Chaudhury A, Zhang M. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016; 126(7):2678-2688.","DOI":"10.1172\/JCI85834"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283062\/76158","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283062\/76796","content-type":"application\/octet-stream","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283062\/76798","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11289\/76158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:01Z","timestamp":1794045901000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,3,31]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283062","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,5]]}}}